Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD will Unveil promising Age Reversal Drug from Telomir Pharmaceuticals

 Dr. Roizen will present promising pre-clinical research on Telomir-1 as Telomir’s special advisor on age reversal.

Telomir’s pre-clinical research supports its belief that enlongating telomeres could stimulate stem cell renewal and provide a treatment for age-related conditions.

“Our event at the NPC will provide an opportunity to share Telomir-1’s potential with the public,” states Chris Chapman, MD, CEO  and president of Telomir Pharmaceuticals. “We will showcase our pre-clinical data which we believe demonstrates that Telomir-1 may potentially treat age-related conditions and prolong human life.”

“Having recently shared our pre-clinical results with our peers at several longevity conferences, we believe that the opportunity to share our data with the public at this juncture is very important,” said Dr. Roizen. “Telomir-1’s results thus far have been extremely encouraging and, we are confident that the findings will be of interest to the entire longevity community. As Telomir continues to uncover new and promising data through our pre-clinical work, we remain committed to sharing our data publicly. I believe that the work that Telomir is undertaking to develop and commercialize Telomir-1 may finally provide an answer to the fight against diseases of aging.”

To RSVP for NPC event and press inquiries: Kandi Amelon (323) 697-7767 [email protected]